RECTAL SUPPOSITORIES BASED ON MODIFIED BACTERIOPHAGE MS2 FOR TARGETED THERAPY OF MALIGNANT SOLID TUMOURS

摘要

FIELD: medicine; pharmaceuticals.;SUBSTANCE: invention refers to pharmaceutical industry, biotechnology and can be used to develop a dosage form of an antitumour agent with a wide spectrum of action. Disclosed is a pharmaceutical composition for treating malignant solid tumours, presented in the form of rectal suppositories, which contains a thallium-containing surface modified bacteriophage MS2 as an active component and a hydrophilic base in a weight ratio of 1:1.;EFFECT: invention provides preparing a dosage form of the preparation having high bioavailability and accelerated therapeutic effect.;1 cl, 5 ex